Comparable stake leader
UNITED BIOMEDICAL INC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001851657.
Comparable stake leader
UNITED BIOMEDICAL INC
Disclosed value leader
UNITED BIOMEDICAL INC
Comparable rows
0/19
Latest evidence
03 Nov 2023
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
0 of 19 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Value bars compare disclosed positions; verify each figure against the linked filing evidence.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| UNITED BIOMEDICAL INC |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$93,436,231
55,949,839 shares
|
— | 16 Jun 2022 |
| Prime Movers Lab Fund I LP |
3/4/5
10%+ Owner
|
—
class O/S missing
|
$27,817,357
16,657,100 shares
|
— | 06 Sep 2023 |
| Mei Mei Hu |
3/4/5
Chief Executive Officer and President., Director, 10%+ Owner
|
—
class O/S missing
|
—
73,928 shares
|
— | 07 Mar 2023 |
| Gregory R. Blatt |
3/4/5
Director
|
—
mixed-class rows
|
$1,525,812
1,042,847 shares
mixed-class rows
|
— | 21 Jun 2022 |
| Farshad Guirakhoo |
3/4/5
Chief Scientific Officer
|
—
mixed-class rows
|
$114,637
126,730 shares
mixed-class rows
|
— | 03 May 2022 |
| Martin Doran |
3/4/5
Officer
|
—
class O/S missing
|
$37,889
22,688 shares
|
— | 10 Nov 2021 |
| James Chui |
3/4/5
Director
|
—
mixed-class rows
|
$23,380
143,187 shares
mixed-class rows
|
— | 21 Jun 2022 |
| Sumita Ray |
3/4/5
Chief Legal, Comp & Admin Off
|
—
class O/S missing
|
—
425,000 shares
|
— | 01 Nov 2023 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Insider buy and sell flow is broadly balanced over the last 12 months. No Buy or Sell transactions have been reported since 04 Jun 2025.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 0 | $0 | $0 | $0 |
| 3-6 | 0 | 0 | $0 | $0 | $0 |
| 6-9 | 0 | 0 | $0 | $0 | $0 |
| 9-12 | 0 | 0 | $0 | $0 | $0 |
Reporting owners
Showing 1-19 of 19 reporting-owner rows connected to Vaxxinity, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| No insider transactions were found in the last 12 months for this issuer. | ||||||||||